Mobile Site ›

Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation


Subscribe

Receive notification when new Hot Topics are published:

Summary

Slide 15

January 2011

In summary, the autoimmune GI dysmotility serological evaluation aids the investigation of new onset idiopathic GI dysmotility. Detection of one or more of this profile of autoantibodies may lead to detection of unsuspected cancer and seropositivity will indicate a potentially immunotherapy responsive disorder.

Summary

 


Jump to section:


Key